In 2020 many contributions have been produced on SLE. Our critical digest of the recent literature will be focused genetic factors that contribute to development disease, novel potential therapeutic targets (including IL-23, IL-17, interferons and JAKs), diagnostic prognostic biomarkers, classification criteria, clinical manifestations comorbidities. We then present new treatment options (with ...